Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Act Repaglinide.
HEALTH CANADA ADVISORY
July 31, 2015
Health Canada has issued new restrictions concerning the use of gluconorm (repaglinide). To read the full Health Canada Advisory, visit Health Canada's web site at www.hc-sc.gc.ca.
Blood sugar control: If you are exposed to extra stress such as fever, trauma, infection, or surgery, your blood sugar control may vary. Monitor your blood sugar carefully and call the doctor if any important changes occur in your control.
Hypoglycemia (low blood sugar): Hypoglycemia (low blood sugar) can occur when taking repaglinide. If you experience low blood sugar (e.g., headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery) while taking Act Repaglinide, contact your doctor.
Kidney function: If you have decreased kidney function, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Act Repaglinide, and whether any special monitoring is needed.
Liver function: Reduced liver function may cause higher levels of repaglinide in the body and increase the risk for low blood sugar levels (hypoglycemia). Make sure you report all your medical conditions to your doctor(s). People with severe liver disease should not take repaglinide.
Missed or delayed meals: This medication acts by promoting the secretion of insulin and should be taken before meals. If a meal is skipped or delayed, the dosing of repaglinide should be skipped or delayed as well.
Pregnancy: Act Repaglinide should not be used during pregnancy. If you become pregnant while taking Act Repaglinide, contact your doctor immediately.
Breast-feeding: It is not known whether repaglinide passes into breast milk. If you are a breast-feeding mother and are taking Act Repaglinide, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: This safety and effectiveness of using this medication have not been established for children.